论文部分内容阅读
目的分析胃癌全胃切除结肠代胃术在临床上取得的治疗效果。方法回顾性分析我院收治的30例以全胃切除治疗胃癌的患者的临床资料。结果全部患者中间置结肠代胃13例(43.33%),幽门结肠代胃17例(56.67%)。同时治疗后对30例患者进行随访,1年死亡2例,生存率为93.33%;2年死亡4例,生存率86.67%;3年死亡8例生存率73.33%;5年死亡16例,生存率46.67%。术后半年患者恢复正常的一日三餐,日平均进食量控制在350g左右,进食后无饱胀感。术后体重恢复良好,血红蛋白、血清蛋白等生化值均维持在正常水平内。查肝肾功能、心电图正常。结论结肠代胃消化道重建术对于胃癌全胃切除患者术后早期营养状况的改善效果显著,值得临床广泛应用。
Objective To analyze the clinical therapeutic effect of total gastrectomy for colonic gastrectomy. Methods The clinical data of 30 patients undergoing total gastrectomy for gastric cancer were retrospectively analyzed in our hospital. Results Thirteen patients (43.33%) had colon metaplasia and 17 patients (56.67%) had pyloric colon. At the same time, 30 patients were followed up after treatment. Two patients died in one year and the survival rate was 93.33%. Four patients died in two years and the survival rate was 86.67%. The three-year death rate was 73.33% in 8 cases and 16 cases in 5 years. The rate is 46.67%. Six months after the patient returned to normal three meals a day, the average daily food intake was controlled at about 350g, and there was no feeling of fullness after eating. Postoperative weight recovered well, and biochemical values such as hemoglobin and serum albumin remained within normal levels. Check liver and kidney function, ECG normal. Conclusion Colonic gastro-intestinal reconstruction of the digestive tract has significant effect on the early postoperative nutritional status of patients undergoing total gastrectomy for gastric cancer and is worthy of clinical application.